PLX
Protalix Biotherapeutics Inc
2.80$
+2.2%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | -238.3% | |
| – | -24.5% | -16.3% | -3.2% | -13.0% | -3.2% | -19.5% | -14.1% | -2.9% | +9.7% | +9.5% | +12.3% | |
| – | +45.1% | -45.2% | -65.9% | +52.5% | +62.5% | +274.4% | -24.0% | -12.2% | +65.4% | -5.7% | -29.4% | |
| – | +642.8% | -284.5% | – | -98.8% | +67.7% | +232.3% | +29.9% | -84.6% | – | – | – | |
| – | – | – | +2,505.5% | -53.5% | -150.5% | – | – | -221.4% | – | – | -1,345.3% | |
| – | -40.9% | +83.0% | +14.4% | -29.4% | -8.6% | +4.5% | +122.7% | -57.0% | +83.0% | +11.6% | +27.8% | |
| – | – | -102.5% | +15.7% | -47.2% | +49.4% | +2,159.6% | – | -126.6% | +231.9% | – | -156.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,060.9% | -97.4% | -100.0% | – | – | – | -1.0% | -82.2% | +199.4% | -85.3% | +157.2% | |
| – | +0.0% | +0.0% | -107.2% | +234.9% | -95.5% | +0.0% | +15,770.7% | -100.0% | – | – | -100.0% | |
| – | +14,323.9% | +196.8% | -107.2% | +234.9% | – | +0.0% | -74.0% | -31.8% | +199.4% | -168.1% | – | |
| – | – | -160.6% | – | – | – | – | +4,280.5% | -205.6% | – | -159.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -284.4% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.